<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Enzyme Inhib Med Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Enzyme Inhib Med Chem</journal-id><journal-title-group><journal-title>Journal of Enzyme Inhibition and Medicinal Chemistry</journal-title></journal-title-group><issn pub-type="ppub">1475-6366</issn><issn pub-type="epub">1475-6374</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7671598</article-id><article-id pub-id-type="pmid">33187452</article-id><article-id pub-id-type="doi">10.1080/14756366.2020.1844681</article-id><article-id pub-id-type="publisher-id">1844681</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Differences in the efficiency of 3-deazathiamine and oxythiamine pyrophosphates as inhibitors of pyruvate dehydrogenase complex and growth of HeLa cells <italic>in&#x000a0;vitro</italic></article-title><alt-title alt-title-type="left-running-head">E. Grabowska et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5352-6933</contrib-id><name><surname>Grabowska</surname><given-names>Ewa</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2113-8802</contrib-id><name><surname>Czerniecka</surname><given-names>Magdalena</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3117-3310</contrib-id><name><surname>Czy&#x0017c;ewska</surname><given-names>Urszula</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1875-8154</contrib-id><name><surname>Zambrzycka</surname><given-names>Aneta</given-names></name><xref ref-type="aff" rid="AF0003">c</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1168-8077</contrib-id><name><surname>&#x00141;otowski</surname><given-names>Zenon</given-names></name><xref ref-type="aff" rid="AF0004">d</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0311-2705</contrib-id><name><surname>Tylicki</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><aff id="AF0001"><label>a</label><institution>Doctoral School of Exact and Natural Sciences, University of Bia&#x00142;ystok</institution>, <city>Bia&#x00142;ystok</city>, <country>Poland</country></aff><aff id="AF0002"><label>b</label><institution>Department of Microbiology and Biotechnology, University of Bia&#x00142;ystok</institution>, <city>Bia&#x00142;ystok</city>, <country>Poland</country></aff><aff id="AF0003"><label>c</label><institution>Argenta Sp. z o.o</institution>, <city>Pozna&#x00144;</city>, <country>Poland</country></aff><aff id="AF0004"><label>d</label><institution>Department of Organic Chemistry, University of Bia&#x00142;ystok</institution>, <city>Bia&#x00142;ystok</city>, <country>Poland</country></aff></contrib-group><author-notes><corresp id="AN0001"><bold>CONTACT</bold> Ewa Grabowska <email>e.grabowska@uwb.edu.pl</email><institution>Doctoral School of Exact and Natural Sciences, University of Bia&#x00142;ystok</institution>, <addr-line>Konstantego Cio&#x00142;kowskiego 1K</addr-line>, <city>Bia&#x00142;ystok</city><postal-code>15-245</postal-code>, <country>Poland</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>11</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><volume>36</volume><issue>1</issue><fpage seq="11">122</fpage><lpage>129</lpage><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IENZ_36_1844681.pdf"/><abstract><title>Abstract</title><p>Oxythiamine (OT) and 3-deazathiamine (DAT) are the antimetabolites of thiamine. The aim of study was to compare the effects of OT and DAT pyrophosphates (-PP) on the kinetics of mammalian pyruvate dehydrogenase complex (PDHC) and the <italic>in&#x000a0;vitro</italic> culture of HeLa cells. The kinetic study showed that 3-deazathiamine pyrophosphate (DATPP) was a much stronger competitive inhibitor (<italic>K<sub>i</sub></italic> = 0.0026&#x02009;&#x003bc;M) of PDHC than OTPP (<italic>K<sub>i</sub></italic> = 0.025&#x02009;&#x003bc;M). Both <italic>K<sub>i</sub></italic> values were much lower versus <italic>K</italic><sub>m</sub> for thiamine pyrophosphate (0.06&#x02009;&#x003bc;M). However, DATPP added to the culture medium for the HeLa cells culture did not hamper the rate of cell growth and showed not significant impact on the viability of the cells, whereas OTPP and OT showed a significant cytostatic effect. The differences between the thiamine antivitamins in their effect on cell growth <italic>in&#x000a0;vitro</italic> may be due to differences in physicochemical properties and difficulty in DAT transport across the cell membrane.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Apoptosis</kwd><kwd>thiamine antimetabolites</kwd><kwd>thiamine pyrophosphate-dependent enzyme inhibitors</kwd></kwd-group><counts><fig-count count="9"/><table-count count="3"/><page-count count="8"/><word-count count="5468"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001" disp-level="1"><title>Introduction</title><p>Thiamine (<xref ref-type="fig" rid="F0001">Figure 1</xref>, No. <bold>1</bold>) is one of the most important vitamins needed for proper cell metabolism. It performs several functions, of which the main is its role as a cofactor of important enzymes, such as pyruvate dehydrogenase complex (PDHC), transketolase, 2-oxoglutarate dehydrogenase complex and pyruvate decarboxylase<xref rid="CIT0001" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="CIT0002" ref-type="bibr"><sup>2</sup></xref>. For many years, several antimetabolites of thiamine [such as amprolium, metronidazole, pyrithiamine or oxythiamine (OT)] have been synthesised and tested as antibiotics or cytostatics<xref rid="CIT0003" ref-type="bibr"><sup>3&#x02013;6</sup></xref>.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Structure of thiamine (<bold>1</bold>), 3-deazathiamine (<bold>2</bold>) and oxythiamine (<bold>3</bold>).</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0001_B"/></fig><p>3-Deazathiamine (DAT, <xref ref-type="fig" rid="F0001">Figure 1</xref>, No. <bold>2</bold>) is a compound known from the beginning of the 21st century. It was synthesised for the first time by Hawksley et&#x000a0;al.<xref rid="CIT0007" ref-type="bibr"><sup>7</sup></xref>. The main difference between thiamine and this antivitamin is that it lacks the N3 cation in the thiazolium ring, which is replaced by a carbon atom. This modification prevents the formation of ylide and thus affects the catalysis after the incorporation of the derivative into the active centre of thiamine pyrophosphate (TPP) dependent enzymes. Currently, this compound is synthesised in two ways. The first one involves the use of 2-acetylbutyrolactone as a substrate for the formation of thiazolium ring. Pyrimidine ring is synthesised from acetamidine hydrochlorine and 3-anilinopropionitrile<xref rid="CIT0008" ref-type="bibr"><sup>8</sup></xref>. In the second way, the same substrate is used for pyrimidine ring synthesis, but 3-methylthiophene is used as the first compound for the formation of thiazolium ring<xref rid="CIT0009" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="CIT0010" ref-type="bibr"><sup>10</sup></xref>. Studies on the impact of the DAT pyrophosphate (DATPP) on the activity of TPP-dependent enzymes have been done on <italic>Zymomonas mobilis</italic> pyruvate decarboxylase (25000 times stronger binding than TPP) and <italic>Escherichia coli</italic> 2-oxoglutarate dehydrogenase complex (about 500 times stronger binding than TPP) only<xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref>. Despite the great importance of PDHC in cell metabolism, no data are available showing the effect of DAT on the parameters of the enzymes from mammalian cells. Similarly, despite the proven inhibitory properties of DAT on the above mentioned TPP-dependent enzymes from bacteria<xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref> (properties that may indicate a potential cytostatic effect of this derivative), there is no information in the literature about the interaction of DAT with cell <italic>in&#x000a0;vitro</italic> models.</p><p>OT (<xref ref-type="fig" rid="F0001">Figure 1</xref>, No. <bold>3</bold>), in contrast to DAT, is one of the best-known antivitamins of thiamine. Research done in 1984 on transketolase and PDHC isolated from rat adrenals showed that the enzymes are inhibited in the presence of OT<xref rid="CIT0012" ref-type="bibr"><sup>12</sup></xref>. Most importantly, another study<xref rid="CIT0013" ref-type="bibr"><sup>13</sup></xref> showed four times lower activity of PDHC after the injection of OT (1&#x02009;mM/kg of rats&#x02019; body weight), suggesting that this compound may be an inhibitor of TPP-dependent enzymes <italic>in&#x000a0;vivo</italic>. Moreover, OT has been assumed to inhibit the growth of cancer cells. A study done on PC-12 cells showed over 90% inhibition of cell growth (depending on the concentration and duration of incubation)<xref rid="CIT0014" ref-type="bibr"><sup>14</sup></xref>. Research performed on two models, <italic>Caco-2</italic><xref rid="CIT0015" ref-type="bibr"><sup>15</sup></xref> cells and rat membrane vesicles<xref rid="CIT0016" ref-type="bibr"><sup>16&#x02013;18</sup></xref> showed that in the presence of OT, thiamine transport is reduced (in the case of rat membrane vesicles, from about 20% up to about 70%<xref rid="CIT0016" ref-type="bibr"><sup>16&#x02013;18</sup></xref>). However, OT may have no effect on thiamine transport as well (as shown by a study on BeWo human trophoblasts<xref rid="CIT0019" ref-type="bibr"><sup>19</sup></xref>). In addition, OT also may decrease the cell viability of colon carcinoma<xref rid="CIT0020" ref-type="bibr"><sup>20</sup></xref>. The impact of OT was also studied on the cells of fungi, such as <italic>Malassezia pachydermatis</italic>, <italic>Saccharomyces cerevisiae</italic> and <italic>Candida albicans</italic><xref rid="CIT0005" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="CIT0006" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="CIT0021" ref-type="bibr"><sup>21</sup></xref>. Research shows that OT can influence the lipid content in fungal cells<xref rid="CIT0021" ref-type="bibr"><sup>21</sup></xref>. It decreased the amount of polyunsaturated fatty acids in <italic>C. albicans</italic> cells, unlike <italic>S. cerevisiae</italic><xref rid="CIT0021" ref-type="bibr"><sup>21</sup></xref>, while opposite results were shown for monounsaturated fatty acids<xref rid="CIT0021" ref-type="bibr"><sup>21</sup></xref>. Moreover, another research using <italic>S. cerevisiae</italic> cells which focussed on the activity of TPP dependent enzymes in the presence of OT showed that this compound may be a stronger inhibitor of mitochondrial enzymes (such as PDHC decrease by 50%) than the TPP-dependent enzymes present in the cytosol (such as pyruvate decarboxylase)<xref rid="CIT0006" ref-type="bibr"><sup>6</sup></xref>. A study done on <italic>M. pachydermatis</italic> showed that, among the several antivitamins of thiamine, OT has the strongest fungicidal effect<xref rid="CIT0005" ref-type="bibr"><sup>5</sup></xref>.</p><p>Based on the limited data available on the inhibitory properties of DAT in relation to some TPP-dependent enzymes isolated from microorganisms, it can be assumed that this antimetabolite should have similar properties in other organisms and other TPP-dependent enzymes like PDHC from mammals. The above assumption allows us to hypothesising that DAT, by inhibiting TPP-dependent enzymes, will reduce the rate of cell growth <italic>in&#x000a0;vitro</italic> and limit cell viability. In this work, we decided to test the above hypothesis by comparing the effects of the well-known thiamine antivitamin OT with the properties of DAT against the PDHC isolated from the porcine heart. In addition, we compared the effects of the above-mentioned thiamine antivitamins on HeLa cancer cells <italic>in&#x000a0;vitro</italic>. The obtained results will provide the basis for assessing the cytostatic properties of DAT against cancer cells.</p></sec><sec sec-type="materials" id="S0002" disp-level="1"><title>Materials and methods</title><sec id="S0002-S2001" disp-level="2"><title>Sources of DAT, OT and their phosphate derivatives</title><p>Three compounds were analysed in the study &#x02013; OT, OT pyrophosphate (OTPP) and 3-deazathiamine pyrophosphate (DATPP). OT was bought from Sigma Aldrich (catalog number: O400) and OTPP as well as DATPP was synthesised in the Faculty of Chemistry, University of Bia&#x00142;ystok, as described below.</p><p>DAT synthesis (<xref ref-type="fig" rid="F0001">Figure 1</xref>, No. <bold>2</bold>) was carried out according to the procedure described by Hawksley et&#x000a0;al.<xref rid="CIT0007" ref-type="bibr"><sup>7</sup></xref> (<xref ref-type="fig" rid="F0002">Figure 2</xref>). The transformation of DAT (<xref ref-type="fig" rid="F0003">Figure 3</xref>, No. <bold>2</bold>) into its pyrophosphate ester (<xref ref-type="fig" rid="F0003">Figure 3</xref>, No. <bold>15</bold>) was performed using the method described by Zhao et&#x000a0;al.<xref rid="CIT0009" ref-type="bibr"><sup>9</sup></xref>. The crude product was purified by means of column chromatography on silica gel using methanol/water solvent (8:2 ratio, with 10 drops of ammonia water added for 100&#x02009;ml of eluent). The collected fractions were lyophilised, and DATPP (<xref ref-type="fig" rid="F0003">Figure 3</xref>, <bold>No. 15</bold>) was obtained as a white powder.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Preparation of 3-deazathiamine (according to Hawksley et&#x000a0;al.<xref rid="CIT0008" ref-type="bibr"><sup>8</sup></xref>): (a) SO<sub>2</sub>Cl<sub>2</sub>; (b) 1) AcOH, HCl/H<sub>2</sub>O, 2) Ac<sub>2</sub>O; (c) NCCH<sub>2</sub>COOEt, AcONH<sub>4</sub>, PhMe; (d) NaSH, EtOH; (e) CuBr<sub>2</sub>, <italic>t</italic>-BuONO, CH<sub>3</sub>CN; (f) Zn, AcOH; (g) LiAlH<sub>4</sub>, Et<sub>2</sub>O; (h) MnO<sub>2</sub>, CHCl<sub>3</sub>; (i) PhNH(CH<sub>2</sub>)<sub>2</sub>CN, NaOMe, DMSO, MeOH; (j) CH<sub>3</sub>C(=NH)NH<sub>2</sub>&#x000b7;HCl, NaOEt, EtOH.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0002_B"/></fig><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Preparation of 3-deazathiamine pyrophosphate (according to Zaho et&#x000a0;al.<xref rid="CIT0009" ref-type="bibr"><sup>9</sup></xref>): (a) <italic>p</italic>-TsCl, py; (b) (Bu<sub>4</sub>N)<sub>3</sub>HP<sub>2</sub>O<sub>7</sub>, CH<sub>3</sub>CN.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0003_B"/></fig><p>OTPP (<xref ref-type="fig" rid="F0004">Figure 4</xref>, No. <bold>18</bold>) was obtained from TPP (<xref ref-type="fig" rid="F0004">Figure 4</xref>, No. <bold>16</bold>) in a Sandmeyer-type reaction, which involves the transformation of the amino group from the pyrimidine ring into diazonium salt (<xref ref-type="fig" rid="F0004">Figure 4</xref>, No. <bold>17</bold>; not isolated during the reaction) and conversion of this reactive entity to phenol with water<xref rid="CIT0022" ref-type="bibr"><sup>22</sup></xref>.</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Preparation of oxythiamine pyrophosphate: (a) NO (HCl&#x02009;+&#x02009;NaNO<sub>2</sub>), air; (b) H<sub>2</sub>O.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0004_B"/></fig><p>The NMR data of OTPP (<xref ref-type="fig" rid="F0004">Figure 4</xref>, No. <bold>18</bold>) were recorded on a Bruker Avance II spectrometer in D<sub>2</sub>O:</p><p><sup>1</sup>H NMR (400&#x02009;MHz, ref. DSS), &#x003b4;: 9.69 (s, 1H, Ar-H from thiazolium ring), 7.96 (s, 1H, Ar-H from pyrimidine ring), 5.58 (s, 2H, Ar<sub>1</sub>-CH<sub>2</sub>-Ar<sub>2</sub>), 4.12 (m, 2H, Ar-CH<sub>2</sub>-C<underline>H<sub>2</sub></underline>-O), 3.31 (m, 2H, Ar-C<underline>H<sub>2</sub></underline>-CH<sub>2</sub>-O), 2.64 (s, 3H, CH<sub>3</sub>), 2.56 (s, 3H, CH<sub>3</sub>).</p><p><sup>13</sup>C NMR (100&#x02009;MHz, ref. DSS), &#x003b4;: 168.6 (C), 165.6 (C), 154.3 (C&#x02009;+&#x02009;CH), 145.4 (C), 137.3 (CH), 118.0 (C), 66.1 (CH<sub>2</sub>), 52.9 (CH<sub>2</sub>), 30.5 (CH<sub>2</sub>), 23.3 (CH<sub>3</sub>), 13.8 (CH<sub>3</sub>).</p><p><sup>31</sup>P NMR (162&#x02009;MHz, ref. H<sub>3</sub>PO<sub>4</sub>), &#x003b4;: &#x02212;9.72 (dd, <italic>J<sub>1</sub></italic>=7.8&#x02009;Hz, <italic>J<sub>2</sub></italic>=20.8&#x02009;Hz, 1&#x02009;P), &#x02212;11.55 (d, <italic>J</italic>&#x02009;=&#x02009;20.9&#x02009;Hz, 1&#x02009;P).</p></sec><sec id="S0002-S2002" disp-level="2"><title>Isolation of mitochondrial PDHC</title><p>The first part of the experiment was focussed on comparing the effects of OTPP and DATPP on the kinetic properties of PDHC. For this purpose, the enzyme was isolated from porcine heart according to the procedure desribed by Stanley and Perham <xref rid="CIT0023" ref-type="bibr"><sup>23</sup></xref> and modified by Strumilo et&#x000a0;al.<xref rid="CIT0024" ref-type="bibr"><sup>24</sup></xref>. Briefly, porcine tissue was homogenised in a Teflon homogeniser for 3&#x02009;min with 0.15&#x02009;M KCl on ice (tissue to solution ratio 1:5). To isolate mitochondria, the cell homogenate was centrifuged for 7&#x02009;min. at 600&#x02009;&#x000d7;&#x02009;g, and then the obtained supernatant was centrifuged again for 10&#x02009;min at 10,000&#x02009;&#x000d7;&#x02009;g. To purify mitochondria, the pellet was resuspended three times with 0.3&#x02009;M sucrose and centrifuged for 10&#x02009;min at 10,000&#x02009;&#x000d7;&#x02009;g. Finally, mitochondria were suspended with 0.025&#x02009;M phosphate buffer (pH 7.5), in a 1:1 ratio. For the disintegration of mitochondria, the suspension was frozen in liquid N<sub>2</sub> and thawed three times and then centrifuged for 40&#x02009;min. 40,000&#x000d7; g. For PDHC precipitation supernatant was mixed with polyethylene glycol up to 36% and centrifuged 40&#x02009;min at 40,000&#x02009;&#x000d7;&#x02009;g. The precipitate was resuspended with 0.025&#x02009;M phosphate buffer (pH 7.5) and used for enzymological studies.</p></sec><sec id="S0002-S2003" disp-level="2"><title>Measurements of the kinetic properties of PDHC</title><p>To determine the range of saturation of the obtained PDHC preparation with endogenous TPP, the enzyme activity was evaluated (procedure given below) with the addition of exogenous TPP (0.2&#x02009;mM) without antivitamins in relation to evaluation without the addition of TPP in the reaction mixture. The results showed that the saturation of the preparation by endogenous TPP did not exceed 10%. Kinetic calculations were corrected to pure apoform.</p><p>For the estimation of <italic>K</italic><sub>m</sub> and <italic>V</italic><sub>max</sub> of TPP, a solution containing 2&#x02009;mM pyruvate, 2&#x02009;mM NAD<sup>+</sup>, 0.1&#x02009;mM CoA, 1&#x02009;mM Mg<sup>2+</sup> and 1&#x02009;mM DTT in 50&#x02009;mM phosphate buffer (pH 7.8), and 10&#x02009;&#x000b5;l of the PDHC preparation containing TPP at a concentration of 0.02&#x02009;&#x02212;&#x02009;5.0&#x02009;&#x000b5;M were used<xref rid="CIT0024" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="CIT0025" ref-type="bibr"><sup>25</sup></xref>. The changes in the reaction speed of PDHC were measured in the presence of inhibitors (OTPP or DATPP at a concentration of 0.01&#x02009;&#x000b5;M) in the same reaction mixture. Measurements were done on Beckman DU-640 spectrophotometer (wavelength: 340&#x02009;nm). Each measurement was repeated five times. The <italic>K</italic><sub>m</sub> values of coenzyme in the presence of both antivitamins were used for estimating the <italic>K<sub>i</sub></italic> values of the inhibitors in relation to PDHC. For estimating the <italic>K<sub>i</sub></italic> values, we used the formula given below.
<disp-formula id="M0001"><alternatives><graphic xlink:href="IENZ_A_1844681_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d2e636"><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mi mathvariant="normal">I</mml:mi><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>
where <italic>K<sub>i</sub></italic> - inhibition constant; [<italic>I</italic>] - inhibitor&#x02019;s concentration; <inline-formula id="ilm0001"><alternatives><inline-graphic xlink:href="IENZ_A_1844681_ILM0001.jpg"/><mml:math id="d2e679"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mtext>m</mml:mtext><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> - <italic>K</italic><sub>m</sub> of TPP in the presence of inhibitor; and <italic>K</italic><sub>m</sub> - Michaelis constant of TPP.</p></sec><sec id="S0002-S2004" disp-level="2"><title>Impact of antivitamins on <italic>in&#x000a0;vitro</italic> cell culture</title><p>To evaluate the impact of the tested antivitamins on an <italic>in&#x000a0;vitro</italic> cell model, HeLa cells were incubated in a CO<sub>2</sub> incubator (37&#x02009;&#x000b0;C, 5% CO<sub>2</sub>, 95% humidity). Three independent experiments were performed for statistical calculations. All the cultures were maintained in MEM199 medium, with 10% foetal bovine serum and antibiotics (penicillin 50&#x02009;U/ml, streptomycin 50&#x02009;&#x000b5;g/ml). Control cultures (without antivitamins) and experimental variants (with thiamine analogues OT, OTPP and DATPP, at a concentration of 0.005&#x02009;&#x02212;&#x02009;0.02%) were grown until the control variant reached confluence (approximately 3&#x02013;4&#x02009;days).</p><p>The impact of the chosen thiamine analogues was evaluated by analysing the metabolic activity of cells by the MTT test, using Lambda E MWG AG BIOTECH plate reader. For assessing the number of live/dead cells as well as live/dead cells with division into early and late apoptosis Muse&#x02122; Count and Viability and Muse&#x02122; Annexin V &#x00026; Dead Cell kits were used, according to the manufacturer&#x02019;s instructions. To define those parameters of cells, Merck Millipore Muse&#x02122; Cell Analyser (0500&#x02013;3115) was used.</p></sec><sec id="S0002-S2005" disp-level="2"><title>Statistical analysis</title><p>The results were statistically analysed using the Shapiro&#x02013;Wilk <italic>W</italic>-test to identify normal distribution and Levene <italic>L</italic>-test for verifying if the variances were homoscedastic. In the case of the normal distribution of data and homoscedastic variances, the <italic>t</italic>-Student test was used to compare the mean values, while in the case of nonnormal distribution of data, nonparametric test (<italic>U</italic>-Mann&#x02013;Whitney test) was used.</p></sec></sec><sec sec-type="results" id="S0003" disp-level="1"><title>Results</title><p>Measurements of the activity of PDHC in the presence of various concentrations of TPP and with or without tested antivitamins allow to preparation Michaelis Menten and Lineweaver Burk plots (<xref ref-type="fig" rid="F0005">Figure 5A,B</xref>). These plots showed that, in the presence of the natural coenzyme as well as anticoenzymes, PDHC exhibited hyperbolic kinetics. The addition of both tested anticoenzymes did not affect the <italic>V</italic><sub>max</sub> value but increased the <inline-formula id="ilm0002"><alternatives><inline-graphic xlink:href="IENZ_A_1844681_ILM0002.jpg"/><mml:math id="d2e742"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mtext>m</mml:mtext><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> of PDHC in comparison with the <italic>K</italic><sub>m</sub> of TPP. The Lineweaver Burk model was used to calculate the <italic>K</italic><sub>m</sub> and <italic>V</italic><sub>max</sub> values. The obtained data showed that OTPP and DATPP are competitive inhibitors of PDHC. Knowing the type of inhibition, we could determine the inhibition constant (<italic>K<sub>i</sub></italic>) values for individual anticoenzymes. As it was shown in <xref rid="t0001" ref-type="table">Table 1</xref>, the <italic>K<sub>m</sub></italic> value of TPP was about two times higher than the <italic>K<sub>i</sub></italic> value of OTPP and about 20 times higher than the <italic>K<sub>i</sub></italic> value of DATPP (<xref rid="t0001" ref-type="table">Table 1</xref>). Moreover, the <italic>K<sub>i</sub></italic> value of OTPP was about 10 times higher than that of DATPP.</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>(A) Michaelis-Menten and (B) Lineweaver-Burk plots of pyruvate dehydrogenase complex properties in the presence of tested compounds (concentration of TPP: 0.02&#x02013;5&#x02009;&#x000b5;M; concentration of OTPP and DATPP: 0.01&#x02009;&#x000b5;M). DATPP: 3-deazathiamine pyrophosphate; OTPP: oxythiamine pyrophosphate; TPP: thiamine pyrophosphate.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0005_B"/></fig><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Comparison of the <italic>K</italic>m of thiamine pyrophosphate (TPP), <italic>K<sub>i</sub></italic> value of oxythiamine pyrophosphate (OTPP) or 3-deazathiamine pyrophosphate (DATPP), <italic>K</italic><sub>m</sub>/<italic>K<sub>i</sub></italic> ratio and <italic>V</italic><sub>max</sub> of pyruvate dehydrogenase complex</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Coenzyme/ anticoenzyme</th><th colspan="3" align="center">Kinetic parameters<hr/></th><th align="center">&#x000a0;</th></tr><tr><th align="center"><italic toggle="yes">K</italic><sub>m</sub> (&#x000b5;M)</th><th align="center"><italic toggle="yes">K<sub>i</sub></italic> (&#x000b5;M)</th><th align="center"><italic toggle="yes">K</italic><sub>m</sub>/<italic toggle="yes">K<sub>i</sub></italic></th><th align="center"><italic toggle="yes">V</italic><sub>max</sub> (U/min)</th></tr></thead><tbody valign="top"><tr><td align="left">TPP</td><td align="center">0.06&#x02009;&#x000b1;&#x02009;0.015</td><td align="char" char="&#x000b1;">&#x02014;</td><td align="center">&#x02014;</td><td align="char" char="&#x000b1;">2.22&#x02009;&#x000b1;&#x02009;0.088</td></tr><tr><td align="left">OTPP</td><td align="center">&#x02014;</td><td align="char" char="&#x000b1;">0.025&#x02009;&#x000b1;&#x02009;0.015<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref></td><td align="center">2.4</td><td align="char" char="&#x000b1;">2.1&#x02009;&#x000b1;&#x02009;0.063</td></tr><tr><td align="left">DATPP</td><td align="center">&#x02014;</td><td align="char" char="&#x000b1;">0.0026&#x02009;&#x000b1;&#x02009;0.0009<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref><sup>,b</sup></td><td align="center">23.1</td><td align="char" char="&#x000b1;">2.18&#x02009;&#x000b1;&#x02009;0.42</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><sup>a</sup>Statistically significant differences between the <italic>K<sub>m</sub></italic> of TPP and the <italic>K<sub>i</sub></italic> of OTPP or DATPP (<italic>U</italic>-Mann&#x02013;Whitney test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn><fn id="TF2"><p><sup>b</sup>Statistically significant differences between the <italic>K<sub>i</sub></italic> of OTT and DTPP (<italic>U</italic>-Mann&#x02013;Whitney test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn></table-wrap-foot></table-wrap><p>Experiments on <italic>in&#x000a0;vitro</italic> cell culture were conducted to determine the amount of cells (dead/live), their metabolic activity (MTT test) and the intensity of apoptosis.</p><p>A comparison of the number of cells in the presence of OT, OTPP or DATPP showed that the least effective thiamine analogue among the three derivatives tested was DATPP. OT and OTPP reduced the number of HeLa cells after 4&#x02009;days of incubation by 80% compared with control (<xref ref-type="fig" rid="F0006">Figure 6)</xref>. In the presence of DATPP, only a slight decrease in cell number was observed (<xref ref-type="fig" rid="F0006">Figure 6</xref>).</p><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Comparison of the total amount of cells after 4&#x02009;days of HeLa cells culture with different concentrations of antivitamins (0.005%, 0.01%, 0.02%). CG: control group; DATPP: 3-deazathiamine pyrophosphate; OT: oxythiamine; OTPP: oxythiamine pyrophosphate; statistically significant differences in relation to control group: <sup>1&#x02009;</sup><italic>U</italic>-Mann&#x02013;Whitney test; <sup>2</sup><italic>t</italic>-Student test; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0006_B"/></fig><p>The MTT test was performed for all experimental variants which contained different concentrations of the tested thiamine antivitamins. The results showed that the most effective antivitamins were OT and OTPP. DATPP caused a decrease in the metabolic activity of HeLa cells as well, but to a lower extent (<xref rid="t0002" ref-type="table">Table 2</xref>). After the incubation of HeLa cells with OT and OTPP, over 50% (concentration 0.005%) and over 60% (concentration 0.02%) decrease in metabolic activity were observed in comparison to control. On the other hand, after incubation with DATPP, the reduction in the metabolic activity of cells did not exceed 50%.</p><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Comparison of the results of MTT test for HeLa cells in the presence of oxythiamine (OT), oxythiamine pyrophosphate (OTPP), 3-deazathiamine pyrophosphate (DATPP), data are presented as percentage in relation to the control group including the number of cells in specific groups (as a percentage of control group)</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th colspan="3" align="center">Concentration of antivitamin<hr/></th></tr><tr><th align="left">Antivitamin</th><th align="center">0.005%</th><th align="center">0.01%</th><th align="center">0.02%</th></tr></thead><tbody valign="top"><tr><td align="left">OT [% of the control group]</td><td align="char" char=".">46<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 15</td><td align="char" char=".">40<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 16</td><td align="char" char=".">38<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 16</td></tr><tr><td align="left">OTPP [% of the control group]</td><td align="char" char=".">45<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 15</td><td align="char" char=".">37<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 16</td><td align="char" char=".">38<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 16</td></tr><tr><td align="left">DATPP [% of control group]</td><td align="char" char=".">54<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 12</td><td align="char" char=".">59<xref ref-type="bibr" rid="CIT0001"><sup>a</sup></xref> &#x000b1; 12</td><td align="char" char=".">51<sup>a</sup> &#x000b1; 11</td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p><sup>a</sup>Statistically significant difference in comparison to the control group (<italic>U</italic>-Mann&#x02013;Whitney test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn></table-wrap-foot></table-wrap><p>Sample results obtained by analysing the viability profile of HeLa control culture and after incubation with 0.02% of tested antivitamins are shown in <xref ref-type="fig" rid="F0007">Figure 7</xref>. Data obtained from three independent cultures for each antivitamin are shown in <xref ref-type="fig" rid="F0008">Figure 8</xref>, in which the changes in the percentage of live, dead, and apoptotic cells after incubation with different concentrations of antivitamins are clearly presented. Incubation of cells with OT and OTPP intensified the apoptosis process in a concentration-dependent manner compared to DATPP. The highest percentage of apoptotic cells was observed at the highest concentrations of OT and OTPP, while DATPP increased the apoptotic cells only by a much lower number. Simultaneously, after incubation with OT and OTPP, we observed a significantly reduced number of live cells (about 50%) in comparison to control and DATPP variants.</p><fig id="F0007" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Viability of HeLa cells after 4&#x02009;days of culture on (A) control medium, (B) oxythiamine-containing medium, (C) oxythiamine pyrophosphate-containing medium and (D) 3-deazathiamine pyrophosphate-containing medium. The concentration of all antivitamins was 0.02%.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0007_B"/></fig><fig id="F0008" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Comparison of the percentages of (A) live, (B) apoptotic and (C) dead HeLa cells after 4&#x02009;days of incubation with thiamine antivitamins: oxythiamine (OT), oxythiamine pyrophosphate (OTPP), and 3-deazathiamine pyrophosphate (DATPP). Data compared with the control group (CG): <sup>1</sup>statistically significant difference in comparison with the control group, <italic>t</italic>-Student test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; <sup>2</sup>statistically significant difference in comparison with the control group, <italic>U</italic>-Mann&#x02013;Whitney test, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic content-type="black-white" xlink:href="IENZ_A_1844681_F0008_B"/></fig><p>In conclusion, despite the stronger inhibitory properties of DATPP compared to OTPP, in addition to PDHC, oxythiamine and its diphosphate ester OT exhibited a much stronger cytostatic effect.</p></sec><sec sec-type="discussion" id="S0004" disp-level="1"><title>Discussion</title><p>PDHC is one of the key enzymes of glucose metabolism<xref rid="CIT0026" ref-type="bibr"><sup>26</sup></xref>. The <italic>K<sub>m</sub></italic>&#x000a0;value of TPP in relation to PDHC determined in our study was similar to the value of the enzyme from bovine heart<xref rid="CIT0027" ref-type="bibr"><sup>27</sup></xref> but ten times lower than the <italic>K<sub>m</sub></italic> of the enzyme from European bison heart<xref rid="CIT0028" ref-type="bibr"><sup>28</sup></xref>. In the presence of OTPP, the <italic>K<sub>m</sub></italic> value of TPP increased by about 50%. The relation between the <italic>K<sub>m</sub></italic> value of TPP and the <italic>K<sub>i</sub></italic> value of OTPP was similar to the data obtained in studies on bovine heart<xref rid="CIT0027" ref-type="bibr"><sup>27</sup></xref> (<italic>K<sub>i</sub></italic> of OTPP was about two times lower than <italic>K<sub>m</sub></italic> of TPP). Referring to the <italic>K<sub>i</sub></italic> values of OTPP obtained in our studies (0.025&#x02009;&#x000b5;M) with the <italic>K<sub>i</sub></italic> values reported in several other papers<xref rid="CIT0012" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="CIT0027" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="CIT0028" ref-type="bibr"><sup>28</sup></xref> it was found that the value was lowest among those measured for PDHC from European bison heart<xref rid="CIT0028" ref-type="bibr"><sup>28</sup></xref>, bovine adrenals<xref rid="CIT0012" ref-type="bibr"><sup>12</sup></xref> and bovine heart<xref rid="CIT0027" ref-type="bibr"><sup>27</sup></xref> (<xref rid="t0003" ref-type="table">Table 3</xref>). In the light of our results and the data obtained by other authors, we can state that PDHC from the porcine heart was the most sensitive to OTPP among the other studied sources. Experiments done on yeast-like fungi (<italic>M. pachydermatis</italic>, <italic>C. albicans</italic> and <italic>S. cerevisiae</italic>) showed that among the thiamine derivatives OT is the best inhibitor of cells growth and affects the activity of pyruvate decarboxylase and malate dehydrogenase<xref rid="CIT0005" ref-type="bibr"><sup>5</sup></xref>.</p><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Comparison of the literature <italic>K</italic><sub>m</sub> values of thiamine pyrophosphate (TPP) and <italic>K<sub>i</sub></italic> values of oxythiamine pyrophosphate (OTPP) from different tissues (PDHC).</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Source of tissue</th><th align="center"><italic toggle="yes">K</italic><sub>m</sub> values of TPP (&#x000b5;M)</th><th align="center"><italic toggle="yes">K<sub>i</sub></italic> values of OTPP (&#x000b5;M)</th><th align="center">References</th></tr></thead><tbody valign="top"><tr><td align="left">European bison heart</td><td align="char" char=".">0.6</td><td align="char" char=".">0.23</td><td align="left">Strumilo et&#x000a0;al.<xref ref-type="bibr" rid="CIT0028"><sup>28</sup></xref></td></tr><tr><td align="left">Bovine adrenals</td><td align="char" char=".">0.11</td><td align="char" char=".">0.07</td><td align="left">Strumi&#x00142;o et&#x000a0;al.<xref ref-type="bibr" rid="CIT0012"><sup>12</sup></xref></td></tr><tr><td align="left">Bovine heart</td><td align="char" char=".">0.07</td><td align="char" char=".">0.04</td><td align="left">Strumilo et&#x000a0;al.<xref ref-type="bibr" rid="CIT0027"><sup>27</sup></xref></td></tr></tbody></table></table-wrap><p>Data obtained by Mann et&#x000a0;al.<xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref> showed that DATPP is the most potent among the known inhibitors of several TPP-dependent enzymes, including pyruvate decarboxylase complex from <italic>Zymomonas mobilis</italic> (<italic>K<sub>i</sub></italic> = 14&#x02009;pM) and &#x003b1;-ketoglutarate dehydrogenase from <italic>E. coli</italic> (<italic>K<sub>i</sub></italic> = 5&#x02009;nM). To our knowledge, no study has been performed analysing the impact of DATPP on PDHC isolated from mammals, but based on previously mentioned data, we can assume that a similar reaction may be observed on TPP-dependent enzymes from mammals. The results obtained by us for the PDHC from porcine heart (<italic>K<sub>i</sub></italic> = 26&#x02009;nM for OTPP) showed that the inhibitory potential of DATPP is lower than in case of microorganisms&#x02019; TPP-dependent enzymes, but it is still high. In contrast to the method used by Mann et&#x000a0;al.<xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref> which involved the inactivation of the enzyme in time under the influence of different DATPP concentrations, we used a kinetic method based on measuring the degree of PDHC inhibition in the presence of an increasing concentration of TPP at a constant concentration of DATPP (0.01&#x02009;&#x003bc;M) added together with coenzyme and involving standard preincubation with the enzyme before starting the reaction of the substrate.</p><p>Our results demonstrate that in the case of PDHC, DATPP as well as OTPP is a competitive inhibitors, which is expected from other results concerning the effect of OTPP on other thiamine-dependent enzymes<xref rid="CIT0005" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref>. Comparing the <italic>K<sub>m</sub></italic> values of TPP with the <italic>K<sub>i</sub></italic> values of the tested antivitamins, we can define DATPP as a better inhibitor of PDHC than OTPP (<italic>K<sub>i</sub></italic> values about 10 times lower). The better inhibition of PDHC by DAT may be related to the structure of this compound. The lack of nitrogen atom in the thiazolium ring may prevent ylide formation more effectively than the lack of an amino group in the case of OTPP. The theoretical chemistry data show that both the mentioned compounds can bind to the active centre of TPP-dependent enzymes with similar docking energy, which is lower in comparison with the native coenzyme<xref rid="CIT0003" ref-type="bibr"><sup>3</sup></xref>.</p><p>The data obtained for PDHC in the presence of OTPP (<xref rid="t0003" ref-type="table">Table 3</xref>) showed higher values of <italic>K<sub>i</sub></italic> in comparison with DATPP. The effect of DATPP on <italic>in&#x000a0;vitro</italic> cell cultures has not been tested till now. Therefore, in our studies, we compared the effects of DATPP and OTPP as well as OT on HeLa cells. Based on the above mentioned enzymological data, we hypothesised that DATPP may reduce the rate of cell growth <italic>in&#x000a0;vitro</italic> and limit the viability of HeLa cells, by more effectively inhibiting the TPP-dependent enzymes than OT or OTPP.</p><p>The <italic>in&#x000a0;vitro</italic> test using HeLa cells showed that OT and OTPP had a stronger cytostatic effect in comparison with DATPP. Considering this, our initial hypothesis should be rejected.</p><p>Despite the strong inhibitory properties of DATPP in relation to PDHC, OTPP proved to be a stronger inhibitor of the growth of HeLa cells. The medium used in this study was carefully chosen to minimise the exogenous source of thiamine and to prove the impact of the chosen thiamine antivitamins independently. The results showed that the most effective as a cytotoxic compound was OT and its pyrophosphate. The reason for the lower sensitivity of cells to DAT may be the inability to transport the compound. Assuming, that thiamine and its derivatives are transported by the same proteins, lack of effectiveness of DATPP as a cytotoxic compound may result from several mechanisms.</p><p>SLC19A1 is a transporter responsible for the transfer of thiamine monophosphate across the cell membrane<xref rid="CIT0026" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="CIT0029" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="CIT0030" ref-type="bibr"><sup>30</sup></xref>. Research done by Mkrtchyan et&#x000a0;al.<xref rid="CIT0031" ref-type="bibr"><sup>31</sup></xref> showed that N2A cells had about five times higher amount of <italic>SLC25A19</italic> mRNA than astrocytes, but at the same time they exhibited similar expression of genes encoding <italic>SLC19A2</italic><xref rid="CIT0031" ref-type="bibr"><sup>31</sup></xref>. However, in some other cancer cells, the expression of genes encoding transporters (such as <italic>SLC19A3, SLC19A2</italic>)<xref rid="CIT0026" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="CIT0032" ref-type="bibr"><sup>32&#x02013;34</sup></xref> is higher than in normal cells. Moreover, some cancer cells show higher expression of genes encoding <italic>SLC25A19</italic> transporter<xref rid="CIT0026" ref-type="bibr"><sup>26</sup></xref>, which may indicate a significant role of this transporter in the availability of thiamine phosphates. All the mentioned data suggest that the specific reaction of HeLa cells in the presence of thiamine derivatives may be related to the expression of genes encoding those transporters as well as the specificity of these transporters.</p><p>OT and OTPP are soluble in water, and so their dephosphorylation, transport and phosphorylation inside the cells may have no impact on their action in contrast to DATPP. Based on our knowledge, DAT is insoluble in water. Therefore, dephosphorylation of DATPP leads to release-free DAT outside the cell and thus could be the other reason responsible for the slight impact of this compound on HeLa cells.</p><p>The impact of OT on eukaryotic cells was studied on mammals (<italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo)</italic> as well as on yeast. Analysis of the amount of cells of <italic>S. cerevisiae</italic> cells showed that OT reduced the total amount of cells<xref rid="CIT0006" ref-type="bibr"><sup>6</sup></xref>. Research done on mice showed the impact of the OT on the Ehrlich&#x02019;s tumour<xref rid="CIT0035" ref-type="bibr"><sup>35</sup></xref>, and this observation was similar to the findings of our research. Data on the impact on fibroblasts showed no differences between the viability of cells with increasing concentrations of OT after 24 and 48&#x02009;h<xref rid="CIT0036" ref-type="bibr"><sup>36</sup></xref>. Our research was maintained for approximately 4&#x02009;days, what may play a role in the viability of cells. These suggest that fibroblasts are less sensitive than HeLa cells to OT treatment. Research done on MIA PaCa-2 cells in <italic>in&#x000a0;vitro</italic> conditions showed that after exposure of cells to OT, their RNA content was reduced by about 45%, as well as the total amount of DNA (decreased by 20%)<xref rid="CIT0037" ref-type="bibr"><sup>37</sup></xref>. Moreover, in the same study, cell proliferation was inhibited by 31 and 41% at OT concentrations of 10<sup>&#x02212;8</sup> &#x000d7; 5&#x02009;&#x000b5;M and 10<sup>&#x02212;7</sup> &#x000d7; 5&#x02009;&#x000b5;M OT, respectively<xref rid="CIT0037" ref-type="bibr"><sup>37</sup></xref>. Moreover, proteomic studies on MIA PaCa-2 cells after exposure to OT showed that the amount of transketolase in cells was lower compared to the control group<xref rid="CIT0038" ref-type="bibr"><sup>38</sup></xref>. In addition, their data<xref rid="CIT0038" ref-type="bibr"><sup>38</sup></xref> showed that the inhibition of transketolase by OT may have a wider impact on the cancer cells (such as activation of the apoptosis pathway). Our experiment done on HeLa cells confirmed the inhibitory properties of OT as well as OTPP.</p><p>From the results, we can summarise that DATPP has no significant impact on HeLa cells unlike OT. As we mentioned previously, the transport of DAT may be difficult. Its availability inside cells might be improved by preparing specific liposomes carrying DATPP or with the use of specific drug carriers<xref rid="CIT0039" ref-type="bibr"><sup>39</sup></xref>.</p><p>In light of our study, we can say that OT has a better cytostatic effect on HeLa cells than DAT. However, from the knowledge gained about the impact of DATPP on the kinetics of PDHC, we conclude that improving accessibility to the cells by the use of alternative transporters can improve the cytostatic effect of DATPP.</p></sec></body><back><sec id="S0005" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>The authors report no conflict of interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Hirsch</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fonzetti</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Vitamin B1 (thiamine) and dementia</article-title>. <source>Ann N Y Acad Sci</source>
<year>2016</year>;<volume>1367</volume>:<fpage>21</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">26971083</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunik</surname><given-names>VI</given-names></name>, <name name-style="western"><surname>Tylicki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lukashev</surname><given-names>NV.</given-names></name></person-group>
<article-title>Thiamin diphosphate-dependent enzymes: from enzymology to metabolic regulation, drug design and disease models</article-title>. <source>Febs J</source>
<year>2013</year>;<volume>280</volume>:<fpage>6412</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">24004353</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tylicki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>&#x00141;otowski</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Siemieniuk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ratkiewicz</surname><given-names>A.</given-names></name></person-group>
<article-title>Thiamine and selected thiamine antivitamins &#x02013; biological activity and methods of synthesis</article-title>. <source>Biosci Rep</source>
<year>2018</year>;<volume>38</volume>:<fpage>1</fpage>&#x02013;<lpage>23</lpage>.</mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agyei-Owusu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Leeper</surname><given-names>FJ.</given-names></name></person-group>
<article-title>Thiamin diphosphate in biological chemistry: analogues of thiamin diphosphate in studies of enzymes and riboswitches</article-title>. <source>Febs J</source>
<year>2009</year>;<volume>276</volume>:<fpage>2905</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">19490097</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siemieniuk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Czyzewska</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Strumilo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tylicki</surname><given-names>A.</given-names></name></person-group>
<article-title>Thiamine antivitamins &#x02013; an opportunity of therapy of fungal infections caused by <italic>Malassezia pachydermatis</italic> and <italic>Candida albicans</italic></article-title>. <source>Mycoses</source>
<year>2016</year>;<volume>59</volume>:<fpage>108</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">26691773</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tylicki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Czerniecki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dobrzyn</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Modification of thiamine pyrophosphate dependent enzyme activity by oxythiamine in <italic>Saccaromyces cerevisiae</italic> cells</article-title>. <source>Can J Microbiol</source>
<year>2005</year>;<volume>51</volume>:<fpage>833</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16333342</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawksley</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Leeper</surname><given-names>FJ.</given-names></name></person-group>
<article-title>Synthesis of 3-deazathiamine</article-title>. <source>J Chem Soc Perkin Trans</source>
<year>2001</year>;<volume>1</volume>:<fpage>144</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>De Meese</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Le Huerou</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Non-charged thiamine analogs as inhibitors of enzyme transketolase</article-title>. <source>Bioorg Med Chem Lett</source>
<year>2008</year>;<volume>18</volume>:<fpage>509</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">18182286</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>de Carvalho</surname><given-names>LPS</given-names></name>, <name name-style="western"><surname>Nathan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ouerfelli</surname><given-names>O.</given-names></name></person-group>
<article-title>A protecting group-free synthesis of deazathiamine: a step toward inhibition design</article-title>. <source>Bioorg Med Chem Lett</source>
<year>2010</year>;<volume>20</volume>:<fpage>6472</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">20943392</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swier</surname><given-names>LJYM</given-names></name>, <name name-style="western"><surname>Monjas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Guskov</surname><given-names>A</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Structure-based design of potent small molecule binders to the S-component of the ECF transporter for thiamine</article-title>. <source>Chem Bio Chem</source>
<year>2015</year>;<volume>16</volume>:<fpage>819</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Melero</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Hawksley</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Leeper</surname><given-names>FJ.</given-names></name></person-group>
<article-title>Inhibition of thiamin diphosphate dependent enzymes by 3-deazathiamin diphosphate</article-title>. <source>Org Biomol Chem</source>
<year>2004</year>;<volume>2</volume>:<fpage>1732</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">15188040</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strumi&#x00142;o</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Senkevich</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Vinogradov</surname><given-names>VV.</given-names></name></person-group>
<article-title>Effect of oxythiamine and adrenal thiamine pyrophosphate-dependent enzyme activities</article-title>. <source>Biomed Biochim Acta</source>
<year>1984</year>;<volume>43</volume>:<fpage>159</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">6732754</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strumi&#x00142;o</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Senkevich</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Galitsky</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Vinogradov</surname><given-names>VV.</given-names></name></person-group>
<article-title>Activity of thiamine pyrophosphate-containing and NADPH-generating enzymes in the rat adrenals after hydroxythiamine administration</article-title>. <source>Biull Exper Biol Med</source>
<year>1983</year>;<volume>96</volume>:<fpage>42</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cornyy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Parkhomenko</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chorna</surname><given-names>N.</given-names></name></person-group>
<article-title>Thiamin deficiency caused by thiamin antagonists triggers upregulation of apoptosis inducing factor gene expression and leads to caspase 3-mediated apoptosis in neuronally differentiated rat PC-12 cells</article-title>. <source>Acta Biocim Polon</source>
<year>2007</year>;<volume>54</volume>:<fpage>315</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lemos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Faria</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Meireles</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Thiamin is a substrate of organic cation transporters in Caco-2 cells</article-title>. <source>Eur J Pharmacol</source>
<year>2012</year>;<volume>682</volume>:<fpage>37</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">22387857</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laforenza</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Gastaldi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rindi</surname><given-names>G.</given-names></name></person-group>
<article-title>Thiamin outflow from the enterocyte: a study using basolateral membrane vesicles from rat small intestine</article-title>. <source>J Physiol</source>
<year>1993</year>;<volume>468</volume>:<fpage>401</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">8254515</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dudeja</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Tyagi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kavilaveettil</surname><given-names>RJ</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Mechanism of thiamin uptake by human jejunal brush-border membrane vesicles</article-title>. <source>Am J Physiol Cell Physiol</source>
<year>2001</year>;<volume>281</volume>:<fpage>C786</fpage>&#x02013;<lpage>C792</lpage>.<pub-id pub-id-type="pmid">11502555</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casirola</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gastaldi</surname><given-names>G</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Transport of thiamin by brush-border membrane vesicles from rat small intestine</article-title>. <source>J Physiol</source>
<year>1988</year>;<volume>398</volume>:<fpage>329</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">3392675</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keating</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lemos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Azevedo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Martel</surname><given-names>F.</given-names></name></person-group>
<article-title>Characteristics of thiamine uptake by the BeWo human trophoblast cell line</article-title>. <source>J Biochem Mol Biol</source>
<year>2006</year>;<volume>39</volume>:<fpage>383</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">16889681</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos-Montoya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>WP</given-names></name>, <name name-style="western"><surname>Bassilian</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer</article-title>. <source>Int J Cancer</source>
<year>2006</year>;<volume>119</volume>:<fpage>2733</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">17019714</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tylicki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siemieniuk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dobrzyn</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Fatty acid profile and influence of oxythiamine on fatty acid content in <italic>Malassezia pachydermatis</italic>, <italic>Candida albicans</italic> and <italic>Saccaromyces cerevisiae</italic></article-title>. <source>Mycoses</source>
<year>2012</year>;<volume>55</volume>:<fpage>e106</fpage>&#x02013;<lpage>e113</lpage>.<pub-id pub-id-type="pmid">22066764</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallo</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Sable</surname><given-names>HZ.</given-names></name></person-group>
<article-title>Conformation of complexes of thiamin pyrophosphate with divalent cations as studied by nuclear magnetic resonance spectroscopy</article-title>. <source>J Biol Chem</source>
<year>1975</year>;<volume>250</volume>:<fpage>4986</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">1150651</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanley</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Perham</surname><given-names>RN.</given-names></name></person-group>
<article-title>Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart &#x02013; a new method</article-title>. <source>Biochem J</source>
<year>1980</year>;<volume>191</volume>:<fpage>147</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">7470091</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strumilo</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Senkevich</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Vinogradov</surname><given-names>VV.</given-names></name></person-group>
<article-title>Purification of pyruvate dehydrogenase complex from bovine adrenal cortex mitochondria</article-title>. <source>Biochem Moscov</source>
<year>1980</year>;<volume>45</volume>:<fpage>883</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czygier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Strumi&#x00142;o</surname><given-names>SA.</given-names></name></person-group>
<article-title>Basic properties of the pyruvate dehydrogenase complex isolated from aurochs heart</article-title>. <source>Acta Biochim Polon</source>
<year>1994</year>;<volume>41</volume>:<fpage>453</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">7732764</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zastre</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sweet</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hanberry</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>S.</given-names></name></person-group>
<article-title>Linking vitamin B1 with cancer cell metabolism</article-title>. <source>Cancer Metab</source>
<year>2013</year>;<volume>1</volume>:<fpage>16</fpage>.<pub-id pub-id-type="pmid">24280319</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strumi&#x00142;o</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>IuV</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Taranda</surname><given-names>NI</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Interaction of the pyruvate dehydrogenase complex from heart muscle with thiamin diphosphate and its derivatives</article-title>. <source>Vopr Med Khim</source>
<year>1989</year>;<volume>35</volume>:<fpage>102</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strumilo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Czygier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Markiewicz</surname><given-names>J.</given-names></name></person-group>
<article-title>Different extent of inhibition of pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase both containing endogeneous thiamine pyrophosphate, by some anticoenzyme analogues</article-title>. <source>J Enzyme Inhib</source>
<year>1995</year>;<volume>10</volume>:<fpage>65</fpage>&#x02013;<lpage>72</lpage>.</mixed-citation></ref><ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Goldman</surname><given-names>ID.</given-names></name></person-group>
<article-title>Reduced folate carrier transports thiamin monophosphate: an alternative route for thiamin delivery into mammalian cell</article-title>. <source>Am J Physiol Cell Physiol</source>
<year>2002</year>;<volume>282</volume>:<fpage>C1512</fpage>&#x02013;<lpage>C1517</lpage>.<pub-id pub-id-type="pmid">11997266</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells</article-title>. <source>J Biol Chem</source>
<year>2001</year>;<volume>276</volume>:<fpage>1114</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">11038362</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mkrtchyan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Graf</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bettendorff</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bunik</surname><given-names>V.</given-names></name></person-group>
<article-title>Cellular thiamine status is coupled to function of mitochondrial 2-oxoglutarate dehydrogenase</article-title>. <source>Neurochem Int</source>
<year>2016</year>;<volume>101</volume>:<fpage>66</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">27773789</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikehata</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iwakawa</surname><given-names>S.</given-names></name></person-group>
<article-title>Different involvement of DNA methylation and histone deacetylation in the expression of soluble-carrier transporters in 4 colon cancer cell lines</article-title>. <source>Biol Pharm Bull</source>
<year>2012</year>;<volume>35</volume>:<fpage>301</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22382314</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>VY</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients</article-title>. <source>PLoS One</source>
<year>2011</year>;<volume>6</volume>:<fpage>e22233</fpage>.<pub-id pub-id-type="pmid">21789241</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer</article-title>. <source>Tumor Biol</source>
<year>2009</year>;<volume>30</volume>:<fpage>242</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="CIT0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ra&#x00131;&#x000a8;s</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Comin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Puigjaner</surname><given-names>J</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich&#x02019;s tumor cells through inhibition of the pentose cycle</article-title>. <source>FEBS Lett</source>
<year>1999</year>;<volume>456</volume>:<fpage>113</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10452541</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szoka</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Karna</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Palka</surname><given-names>J.</given-names></name></person-group>
<article-title>J. The mechanism of oxythiamine-induced collagen biosynthesis in cultured fibroblasts</article-title>. <source>Mol Cell Biochem</source>
<year>2015</year>;<volume>403</volume>:<fpage>51</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">25626895</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boros</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Puigjaner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cascante</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation</article-title>. <source>Cancer Res</source>
<year>1997</year>;<volume>57</volume>:<fpage>4242</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9331084</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>D</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells</article-title>. <source>Exp Hematol Oncol</source>
<year>2013</year>;<volume>2</volume>:<fpage>18</fpage>.<pub-id pub-id-type="pmid">23890079</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gangolf</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Czerniecki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Radermecker</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Thiamine status in human and content of phosphorylated thiamine derivatives in biopsies and cultured cells</article-title>. <source>PLoS One</source>
<year>2010</year>;<volume>5</volume>:<fpage>e-13616</fpage>.<pub-id pub-id-type="pmid">21049048</pub-id></mixed-citation></ref></ref-list></back></article>